503 reports of this reaction
2.0% of all NOREPINEPHRINE reports
#10 most reported adverse reaction
CARDIOGENIC SHOCK is the #10 most commonly reported adverse reaction for NOREPINEPHRINE, manufactured by Professional Complementary Health Formulas. There are 503 FDA adverse event reports linking NOREPINEPHRINE to CARDIOGENIC SHOCK. This represents approximately 2.0% of all 24,944 adverse event reports for this drug.
Patients taking NOREPINEPHRINE who experience cardiogenic shock should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CARDIOGENIC SHOCK is a less commonly reported adverse event for NOREPINEPHRINE, but still significant enough to appear in the safety profile.
In addition to cardiogenic shock, the following adverse reactions have been reported for NOREPINEPHRINE:
The following drugs have also been linked to cardiogenic shock in FDA adverse event reports:
CARDIOGENIC SHOCK has been reported as an adverse event in 503 FDA reports for NOREPINEPHRINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CARDIOGENIC SHOCK accounts for approximately 2.0% of all adverse event reports for NOREPINEPHRINE, making it a notable side effect.
If you experience cardiogenic shock while taking NOREPINEPHRINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.